Integrated circulating tumor DNA-based prognostic algorithm for limited stage small-cell lung cancer under definitive chemoradiotherapy and utility in consolidation immunotherapy benefit prediction
Serial ctDNA monitoring during dCRT is a critical approach to predicting inoperable LS-SCLC progression and consolidation immunotherapy benefit identification.
Authors
- Xiaoxi Chen (ORCID: https://orcid.org/0000-0002-0239-9938)
- Xia Ning (ORCID: https://orcid.org/0000-0002-6842-1165)
- Yao Fu (ORCID: https://orcid.org/0000-0003-4103-0065)
- Naiqing Ding
- Xiaotian Zhao (ORCID: https://orcid.org/0000-0003-3823-3232)
- Jianming Zhou (ORCID: https://orcid.org/0000-0003-3069-5942)
- Hua Bao (ORCID: https://orcid.org/0000-0001-5774-8755)
- Yang Yang (ORCID: https://orcid.org/0000-0002-2636-8933)
Institutions
- Anhui Medical University (CN)
- Zhongda Hospital Southeast University (CN)
- Nanjing Brain Hospital (CN)
- Nanjing Drum Tower Hospital (CN)
- First Affiliated Hospital of Anhui Medical University (CN)
Publication Details
- Journal
- Cell Communication and Signaling
- Published
- 2025-11-07
- DOI
- https://doi.org/10.1186/s12964-025-02462-y
- Primary Topic
- Lung Cancer Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00